FDA Adverse Event Malfunction Summary report: N

HEARTSINE SAMARITAN 300P AND PAD PAK

MDR report key: 3082544 · Received April 23, 2013

Report

Report Number
3004123209-2012-00482
Event Type
Malfunction
Date Received
April 23, 2013
Date of Event
November 20, 2012
Report Date
March 6, 2013
Manufacturer
HEARTSINE TECHNOLOGIES LTD
Product Code
MKJ
PMA / PMN Number
K052465
Removal / Correction Number
Z-0124-2013
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
HO
Reporter Occupation
NOT APPLICABLE

Narratives

Additional Manufacturer Narrative · 1

ROUTINE TESTING CONFIRMED THAT THIS DEVICE WAS INSTALLED BY THE CUSTOMER IN (B)(6) 2009 AND THAT IT HAD PERFORMED TO SPECIFICATION UP TO (B)(6) 2012. INFORMATION OBTAINED FROM THE DEVICE CONFIRMED EVIDENCE THAT THE DEVICE WAS SWITCHING ITSELF ON AUTOMATICALLY RESULTING IN MANUAL POWER-UPS OF 10 MINUTES IN DURATION THAT STARTED ON (B)(6) 2012 AND CONTINUED UP TO ON (B)(6) 2012. INVESTIGATION DID NOT CONFIRM A FAULT WITH THE DEVICE OR ANY COMPONENT IN THE DEVICE. THE DEVICE SWITCHING ITSELF ON IS A KNOWN SYMPTOM OF A DAMAGED OR FAULTY MEMBRANE. ALTHOUGH IN THIS EVENT THERE WAS NO FAULT MEASURED ON THE MEMBRANE IT IS PROBABLE THAT DAMAGE HAS BEEN CAUSED TO THE MEMBRANE, WHICH HAS AFFECTED THE DEVICE CAUSING IT TO SWITCH ITSELF ON AUTOMATICALLY. A DEVICE SWITCHING ITSELF ON AUTOMATICALLY CAN CAUSE PREMATURE DEPLETION OF THE PAD-PAKS (BATTERY). THE PAD PAK, WHICH CONTAINS THE ELECTRODES AND BATTERIES, IS LABELLED FOR SINGLE USE BUT THE SAMARITAN PAD 300 AND 300P DEVICES ARE FOR MULTI-USE.

Description of Event or Problem · 1

THERE WAS NO PATIENT INVOLVED IN THIS EVENT. THIS DEVICE MALFUNCTIONED BECAUSE IT WAS SWITCHING ITSELF ON AUTOMATICALLY. A DEVICE SWITCHING ITSELF ON AUTOMATICALLY, IF LEFT UNDETECTED COULD RESULT IN BATTERY BECOMING DEPLETED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
175152 HEARTSINE SAMARITAN 300P AND PAD PAK AUTOMATED EXTERNAL DEFIBRILLATOR MKJ HEARTSINE TECHNOLOGIES LTD PAD

Patients

Seq Age Sex Outcome Treatment
1